** Inovio Pharmaceuticals INO.O shares down 20.5% at $2.99 post-market as co plans equity raise
** Co, which focuses on treating HPV-related diseases, cancer, and infectious diseases, announces proposed stock and warrants offering; deal size not disclosed
** Oppenheimer and Citizens JMP jt bookrunners
** INO shares on Thurs finished session down 6.6% at $3.76, a record low close
** Plymouth Meeting, Pennsylvania-based firm has ~26.1 mln shares outstanding for ~$98 mln market cap, per LSEG
** YTD, stock has lost ~39%
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。